Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes

被引：0
|
作者：
Ulf Hannelius
Craig A. Beam
Johnny Ludvigsson
机构：
[1] Diamyd Medical AB,Department of Biomedical Sciences
[2] Western Michigan University Homer Stryker M.D. School of Medicine,Division of Pediatrics, Department of Biomedical and Clinical Sciences (BKV), Medical Faculty
[3] Crown Princess Victoria Children’s Hospital,undefined
[4] Linköping University,undefined
来源：
Diabetologia | 2020年 / 63卷
关键词：
Antigen-specific; Autoimmune diabetes; C-peptide; GAD; Glutamic acid decarboxylase; HLA; Immunotherapy; Type 1 diabetes; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2177 / 2181
页数：4
相关论文
共 49 条
  • [41] IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity
    Walter, M
    Albert, E
    Conrad, M
    Keller, E
    Hummel, M
    Ferber, K
    Barratt, BJ
    Todd, JA
    Ziegler, AG
    Bonifacio, E
    DIABETOLOGIA, 2003, 46 (05) : 712 - 720
  • [42] IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity
    M. Walter
    E. Albert
    M. Conrad
    E. Keller
    M. Hummel
    K. Ferber
    B. J. Barratt
    J. A. Todd
    A.-G. Ziegler
    E. Bonifacio
    Diabetologia, 2003, 46 : 712 - 720
  • [43] Genetic-induced Variations in the GAD65 T-cell Repertoire Governs Efficacy of Anti-CD3/GAD65 Combination Therapy in New-onset Type 1 Diabetes
    Bresson, Damien
    Fradkin, Matthew
    Manenkova, Yulia
    Rottembourg, Diane
    von Herrath, Matthias
    MOLECULAR THERAPY, 2010, 18 (02) : 307 - 316
  • [44] ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE ARE ASSOCIATED WITH HLA-DR GENOTYPES IN BOTH AUSTRALIANS AND ASIANS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    SERJEANTSON, SW
    KOHONENCORISH, MRJ
    ROWLEY, MJ
    MACKAY, IR
    KNOWLES, W
    ZIMMET, P
    DIABETOLOGIA, 1992, 35 (10) : 996 - 1001
  • [45] A population-specific diabetogenic haplotype HLA-A2, Cw1, B56, DR4, DQ8 is associated with high birthweight in Finnish diabetic families
    Jaervinen, T. M.
    Harjutsalo, V.
    Kinnunen, L.
    Miettinen, M. E.
    Tuomilehto-Wolf, E.
    Tuomilehto, J.
    GENES AND IMMUNITY, 2008, 9 (03) : 207 - 213
  • [46] THE BGL-II RFLP ASSOCIATED WITH TYPE-1 DIABETES IN DR3-POSITIVE SUBJECTS IS NOT DUE TO A DQA1 PROMOTER REGION POLYMORPHISM
    CAVAN, DA
    KELLY, MA
    JACOBS, KH
    PENNY, MA
    JENKINS, D
    MIJOVIC, C
    BARNETT, AH
    AUTOIMMUNITY, 1994, 17 (02) : 123 - 125
  • [47] Glutamic Acid Decarboxylase 65 and Islet Cell Antigen 512/IA-2 Autoantibodies in Relation to Human Leukocyte Antigen Class II DR and DQ Alleles and Haplotypes in Type 1 Diabetes Mellitus
    Stayoussef, Mouna
    Benmansour, Jihen
    Al-Jenaidi, Fayza A.
    Said, Hichem B.
    Rayana, Chiheb B.
    Mahjoub, Touhami
    Almawi, Wassim Y.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (06) : 990 - 993
  • [48] Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
    Michelle Rosenzwajg
    Randa Salet
    Roberta Lorenzon
    Nicolas Tchitchek
    Alexandra Roux
    Claude Bernard
    Jean-Claude Carel
    Caroline Storey
    Michel Polak
    Jacques Beltrand
    Chloé Amouyal
    Agnès Hartemann
    Pierre Corbeau
    Eric Vicaut
    Cecile Bibal
    Pierre Bougnères
    Tu-Anh Tran
    David Klatzmann
    Diabetologia, 2020, 63 : 1808 - 1821
  • [49] Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
    Rosenzwajg, Michelle
    Salet, Randa
    Lorenzon, Roberta
    Tchitchek, Nicolas
    Roux, Alexandra
    Bernard, Claude
    Carel, Jean-Claude
    Storey, Caroline
    Polak, Michel
    Beltrand, Jacques
    Amouyal, Chloe
    Hartemann, Agnes
    Corbeau, Pierre
    Vicaut, Eric
    Bibal, Cecile
    Bougneres, Pierre
    Tran, Tu-Anh
    Klatzmann, David
    DIABETOLOGIA, 2020, 63 (09) : 1808 - 1821
12345